Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review.

Ammar N, Uginet M, De Stefano P, Quintard H, Samii K, Seebach JD, Dalmau J, Lalive PH

Open source

DOI
10.1212/nxi.0000000000200648
Published
2026 Nov
Container
Neurology(R) neuroimmunology & neuroinflammation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/nxi.0000000000200648,
  title = {Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review.},
  author = {Ammar N and Uginet M and De Stefano P and Quintard H and Samii K and Seebach JD and Dalmau J and Lalive PH},
  year = {2026},
  journal = {Neurology(R) neuroimmunology \& neuroinflammation},
  doi = {10.1212/nxi.0000000000200648},
  url = {https://doi.org/10.1212/nxi.0000000000200648}
}

RIS

TY  - JOUR
TI  - Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review.
AU  - Ammar N
AU  - Uginet M
AU  - De Stefano P
AU  - Quintard H
AU  - Samii K
AU  - Seebach JD
AU  - Dalmau J
AU  - Lalive PH
PY  - 2026
JO  - Neurology(R) neuroimmunology & neuroinflammation
DO  - 10.1212/nxi.0000000000200648
UR  - https://doi.org/10.1212/nxi.0000000000200648
ER  - 

APA

N, A., M, U., P, D. S., H, Q., K, S., JD, S., J, D., & PH, L. (2026). Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review.. Neurology(R) neuroimmunology & neuroinflammation. https://doi.org/10.1212/nxi.0000000000200648

Source records